Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)
Open Access
- 5 September 2022
- journal article
- research article
- Published by Elsevier in IJID Regions
- Vol. 5, 104-110
Abstract
No abstract availableKeywords
All Related Versions
This publication has 24 references indexed in Scilit:
- SARS-CoV-2 Infection after Vaccination in Health Care Workers in CaliforniaNew England Journal of Medicine, 2021
- Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2JCI Insight, 2021
- SARS-CoV-2 Vaccines and the Growing Threat of Viral VariantsJAMA, 2021
- Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020Emerging Infectious Diseases, 2020
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020
- Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19Signal Transduction and Targeted Therapy, 2020
- Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients SemiquantitativelyJournal of Clinical Microbiology, 2020
- Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotypeNature Biotechnology, 2019
- Nextstrain: real-time tracking of pathogen evolutionBioinformatics, 2018
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014